Literature DB >> 10724921

Treatment of missing values with imputation for the analysis of otologic data.

J Laurikkala1, E Kentala, M Juhola, I Pyykkö.   

Abstract

Usefulness of imputation in the treatment of missing values in an otologic database was studied. Missing values were filled in with means (ME), regression (LR) and Expectation-Maximization (EM) imputation methods. A random imputation method (RA) provided baseline results. ME, LR and EM methods agreed on 41-42% of the imputed missing values. The level of agreement between these and RA method was 20-22%. Despite the moderate agreement, discriminant functions were similar and accurate (prediction accuracy 83-99%) for each diagnosis. A lot of data were missing in otoneurotologic tests which have less weight in the diagnosis of vertiginous patients. Consequently, the disagreement of the methods did not affect discriminant analysis. Inputation seems to be a useful method to treat missing data in this database, but future research requires more complete data and advanced imputation methods.

Entities:  

Mesh:

Year:  1999        PMID: 10724921

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  3 in total

1.  Predictive capability of historical data for diagnosis of dizziness.

Authors:  Jeff G Zhao; Jay F Piccirillo; Edward L Spitznagel; Dorina Kallogjeri; Joel A Goebel
Journal:  Otol Neurotol       Date:  2011-02       Impact factor: 2.311

2.  Searching for success: Development of a combined patient-reported-outcome ("PRO") criterion for operationalizing success in multi-modal pain therapy.

Authors:  Carolin Donath; Lisa Dorscht; Elmar Graessel; Reinhard Sittl; Christoph Schoen
Journal:  BMC Health Serv Res       Date:  2015-07-17       Impact factor: 2.655

3.  Validation of a core patient-reported-outcome measure set for operationalizing success in multimodal pain therapy: useful for depicting long-term success?

Authors:  Carolin Donath; Christa Geiß; Christoph Schön
Journal:  BMC Health Serv Res       Date:  2018-02-17       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.